The FDA has approved Jascayd (nerandomilast) as a treatment for a second lung disease, progressive pulmonary fibrosis, following the drug’s initial approval in October 2025 as a treatment for ...
Anok Yai revealed she was diagnosed with a congenital lung defect that was overworking her heart and damaging her lungs. The ...
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced today that it has resubmitted the MOLBREEVI BLA to the FDA, with ...
Scientists at the VIB-UGent Center for Inflammation Research found that alveolar macrophages, normally protective lung immune ...
This feature dwells not so much on the economic benefits that the tobacco industry brought to the Maltese islands, and more on the health problems it created, which in themselves are high social and ...
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...
Winter smog is not merely an environmental nuisance, it poses a serious health threat to people living with Interstitial Lung Diseases ...
Poor air quality impacts the health of children severely. Fine particulate matter like PM2.5, coarse particles such as PM10, ...
Kamada ends its Phase 3 inhaled AAT trial after a futility analysis but maintains 2025 guidance and forecasts double-digit growth in 2026.
A leading GP has warned that people could believe they're suffering from the flu, when in reality they are dealing with a ...
As a neonatologist practicing in the National Capital Region (NCR), I often witness a heartbreaking irony: the very first breath a newborn takes in Gurgaon is often laden with toxins. While the "Great ...
Lung development begins during embryogenesis and continues after birth. It includes branching of airways, formation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback